The QualityStocks Daily Thursday, May 16th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (BNKL) +99.01%

MarketBeat (OTLK) +68.06%

MarketClub Analysis (IOVA) +36.06%

The QualityStocks Daily Stock List

PeerStream, Inc. (PEER)

Zacks, Proactive Investors, TechCrunch, OTC Markets, Marketbeat, Stockwatch, Wallet Investor, Market Screener, Trading View, 4-Traders, Simply Wall St, MarketWatch, and InvestorsHub reported earlier on PeerStream, Inc. (PEER), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

PeerStream, Inc. is a communications software innovator based in New York, New York. The Company is developing enhanced security and privacy solutions for video, voice, and text applications and data transmission. Using multi-layered encryption, blockchain technology and other recent innovations, PeerStream is developing its proprietary PeerStream Protocol (PSP) to offer clients maximum data security and confidentiality over distributed or decentralized networks. PeerStream lists on the OTCQB.

The Company's offerings target consumer, government and enterprise clients. For two decades, PeerStream has built and continues to operate unique consumer applications. These include Paltalk and Camfrog, two of the largest live video social communities.

In addition, PeerStream recently launched its Backchannel product suite in private beta. This includes cross platform applications, middleware and software development kits designed to offer a highly secure end user communication experience when coupled with PSP.

Regarding its Business Solutions, PeerStream helps clients identify advantageous distributed technology strategies and integrate public and private blockchain solutions to advance their business goals. The Company is a pioneer in blockchain technology.

Concerning its Technology Platform, the Company offers a platform for live multimedia streaming and communications, with PeerStream Protocol (PSP). This is an open source peer network for content delivery built with blockchain technology.

Regarding its Consumer Applications, PeerStream's Paltalk is a foremost provider of real-time, rich media, interactive social networking applications with over 200 million registered users worldwide. The Company's Camfrog is a cross-platform global video chat community. Moreover, its Backchannel is a secure messaging app harnessing blockchain for complete privacy.

This past March, ElevenPaths, Telefónica's Cybersecurity Unit, and Rivetz, an industry leader in decentralized hardware-based cybersecurity, announced that PeerStream will join its partnership to offer next-generation zero trust architecture, privacy and security protection for enterprise applications and communications. PeerStream is developing enterprise-grade communications software focusing on enhanced privacy and security that it is planning to bring to market under the Backchannel brand.

The design of Backchannel is to offer a growing set of software tools built to power secure, real-time data and messaging channels that are also planned to support streaming video. At the heart of Backchannel is PeerStream's decentralized network routing technology, PeerStream Protocol (PSP), which may operate on either blockchain or traditional distributed architectures.

PeerStream, Inc. (PEER), closed Thursday's trading session at $3.10, up 11.11%, on 916 volume with 8 trades. The average volume for the last 3 months is 396 and the stock's 52-week low/high is $1.05/$7.50.

chart

CleanSpark, Inc. (CLSK)

Insider Financial, Micro Cap Daily, Financial Buzz, Marketbeat, Equities, GlobeNewswire, Pot Stock News, Insider Tracking, Wallet Investor, Stockwatch, Barchart, Trading View, Uptick Newswire, PR Newswire, Market Screener, Stockhouse, Simply Wall St, YCharts, InvestorsHub, Dividend Investor, and MarketWatch reported previously on CleanSpark, Inc. (CLSK), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

CleanSpark, Inc. is a microgrid company with advanced engineering, software and controls for innovative distributed energy resource (DER) and microgrid deployments. It provides advanced energy software and control technology, which enables a plug-and-play enterprise solution to contemporary energy challenges. CleanSpark's customers include energy consumers and the distributed energy ecosystem at large: developers, installers, EPCs, IPPs, and energy storage vendors. The Company was previously known as Stratean, Inc. It changed its name to CleanSpark, Inc. in November of 2016. OTCQB-listed, CleanSpark is based in Utah.

The Company's services comprise intelligent energy monitoring and controls, microgrid design and engineering, microgrid consulting services, and turn-key microgrid implementation services. CleanSpark's software enables energy users to obtain resiliency and economic optimization. The Company's software is uniquely capable of enabling a microgrid to be scaled to the user's specific needs. It can be widely implemented across commercial, industrial, military, agricultural and municipal, deployment.

CleanSpark's Microgrid Value Stream Optimizer outputs are a client's customized guide to maximizing their energy project's ROI (Return on Investment). State-of-the-art data analytics account for real costs, precise utility rate models, equipment performance, and actual energy consumption. They outline what kind of energy resources are to be built, what it will cost, and how it will perform upon deployment.

Moreover, the Company's mPulse software is an innovation in controls capable of integrating numerous Distributed Energy Resources (DER). This includes storage, renewables and fossil fuel technologies. CleanSpark's intelligent software package collects, archives and analyzes data 24/7 providing real-time control and reporting. Regarding Engineering & Grid Development Services, the Company's mVSO provides critical information. In addition, it is the starting point for CleanSpark's microgrid development services.

Earlier this month, CleanSpark announced it achieved government acceptance of its solar plus storage microgrid located at the Marine Corps Base Camp Pendleton. Completed by general contractor Bethel-Webcor JV, the Communications Information Systems (C.I.S.) Operations Complex includes a data center, headquarters facility, maintenance and supply warehouse, and related communications infrastructure.

The whole project receives backup power from UPS and traditional standby generators provided by other contractors. A subset of the critical loads are served by CleanSpark's advanced solar plus storage microgrid offering perpetual off-grid 100 percent renewable driven energy security via an all iron flow battery DC coupled with solar photovoltaic generation located on both carport shade structures and the buildings' roofs.

Last week, CleanSpark announced it secured $2.5 million in orders for its intelligent automatic transfer switch (ATS) switchgear. Its Intelligent ATS switchgear is used to automatically transfer power supply from its main source to a backup source when it senses a failure or outage in the primary source, therefore assuring uninterrupted power. Additionally, it allows the end user the opportunity to participate in regional energy markets when it makes financial sense to sell surplus power back to the grid.

Today, CleanSpark reported record Revenue growth for its Q2 of fiscal 2019. For the three months ended March 31, 2019, it generated more than $723,899 in sales. This represents an increase of 602 percent year-over-year and a 275 percent increase quarter-over-quarter.

CleanSpark, Inc. (CLSK), closed Thursday's trading session at $2.95, up 8.46%, on 146,294 volume with 256 trades. The average volume for the last 3 months is 197,950 and the stock's 52-week low/high is $1.10/$15.01.

chart

Lixte Biotechnology Holdings, Inc. (LIXT)

Small Cap Network, Street Insider, PR Newswire, 4-Traders, YCharts, OTC Markets, Simply Wall St, Last10k, Market Screener, InvestorsHub, Stockopedia, Dividend Investor, Marketbeat, Stockhouse, Morningstar, and Wallet Investor reported earlier on Lixte Biotechnology Holdings, Inc. (LIXT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

A clinical-stage pharmaceutical company, Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. It uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The Company's product pipeline is mainly centered on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or X-ray and immune checkpoint blockers. Lixte Biotechnology Holdings lists on the OTC Markets Group's OTCQB. The Company is headquartered in East Setauket, New York.

Lixte Biotechnology has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. Its present drug portfolio includes inhibitors of serine/threonine protein phosphatases critical to cell division and DNA damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.

The phosphatase inhibitors enhance the effectiveness of cytotoxic anti-cancer drugs in general and radiation therapy. This makes them potentially useful for the treatment of numerous cancers in combination with existing standard chemotherapy regimens and with the developing targeted cytotoxic therapies of personalized cancer medicine.

Furthermore, in a pre-clinical study done with scientists under collaborative research and development agreements at the National Institutes of Health, the Company's lead compound, LB-100, enhanced the antitumor activity of a major immune checkpoint inhibitor. Therefore, this raises the possibility that in addition to improving the efficacy of standard cytotoxic anti-cancer drugs, Lixte Biotechnology's phosphatase inhibitors may potentiate immunotherapy regimens (Ho 2017).

Yesterday, Lixte Biotechnology announced the opening of a pharmacologic study of the ability of its lead clinical compound, LB-100, to enter the brain and penetrate recurrent glioblastoma multiforme tumors in patients in which surgical removal of their cancers is indicated (clinical trials registry: NCT03027388). The study is being conducted by the National Cancer Institute under a Cooperative Research and Development Agreement (CRADA) with Lixte Biotechnology.

The design of the NCI study is to ascertain the extent to which LB-100 enters recurrent GBMs and related brain tumors. Patients having surgery to remove one or more tumors will receive one dose of LB-100 before surgery and have blood and tumor tissue analyzed for the amount of LB-100 present and to determine whether the cells in the tumors show the biochemical changes expected to be present if LB-100 reaches its molecular target. The objective is to obtain data in up to eight patients.

Lixte Biotechnology Holdings, Inc. (LIXT), closed Thursday's trading session at $1.10, up 7.84%, on 13,858 volume with 20 trades. The average volume for the last 3 months is 2,078 and the stock's 52-week low/high is $0.125/$1.84.

chart

Birchcliff Energy Ltd. (BIREF)

Top Stocks News, Simply Wall St, GlobeNewswire, Stockhouse, Trading View, Marketbeat, Stockwatch, OilandGas360, Canadian Insider, Energy Now, Business Insider, and Market Screener reported earlier on Birchcliff Energy Ltd. (BIREF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

An intermediate oil and natural gas company, Birchcliff Energy Ltd. explores for, develops, and produces natural gas, crude oil, and natural gas liquids in Western Canada. The Company has operations concentrated within its one core area, The Peace River Arch Of Alberta. Birchcliff has considerable in-house technical expertise and experience on the Peace River Arch. Established in 2004, Birchcliff Energy has its corporate headquarters in Calgary, Alberta.

Birchcliff Energy has focused assets in the Peace River Arch Area of Alberta on the Montney/Doig Resource Play. It essentially has a 100 percent working interest (WI); 99 percent of production is operated. The Company has a large, contiguous undeveloped land base with an average 89 percent WI.

Birchcliff Energy has significant control of infrastructure. This includes the 100 percent owned and operated 340 MMcf/d Pouce Coupe Gas Plant (PC Gas Plant). Furthermore, Birchcliff has a low decline production base (estimated 20 percent in 2019), and a top tier cost structure driving peer leading profitability.

Moreover, the Company has a 2P reserve life index (RLI) of roughly 35.6 years as at December 31, 2018. It had 385 (380.6 net) Montney/Doig horizontal wells drilled as at December 31, 2018. In addition, it had 6,365.8 net future potential Montney/Doig horizontal drilling locations as at December 31, 2018.

Birchcliff Energy's key strategic attributes include 18 gross (15.1 net) Montney sections contiguous to existing BIR infrastructure. There is the potential for 4 Montney intervals (Montney D1, D2, C, Basal Doig/Upper Montney). The Company drilled a 6 well pad in Q1 2019. It is to be completed and brought on production in Q3 2019. The strategic land acquisition provides additional liquids rich drilling inventory to fill the Pouce Coupe Gas Plant.

The acquisition included approximately 700 boe/d of legacy production. The acquisition was evaluated mainly on land acquisition metrics and future drilling opportunities. The construction of the 340 MMcf/d PC Gas Plant is in six separate phases and is on time and on budget.

Yesterday, Birchcliff Energy announced its financial and operational results for the three months ended March 31, 2019.

Mr. Jeff Tonken, President and Chief Executive Officer of Birchcliff Energy, said, " "Birchcliff delivered excellent first quarter results, with quarterly average production of 74,844 boe/d and adjusted funds flow of $116.6 million. This is the highest quarterly adjusted funds flow we have recorded since our inception, driven by our significant market diversification initiatives and strong commodity prices, as well as by our near record low operating costs and stable, low-decline production base. We have had strong condensate rates from our wells in Pouce Coupe and strong oil rates from our wells in Gordondale."

Birchcliff Energy Ltd. (BIREF), closed Thursday's trading session at $2.86, up 5.93%, on 193,499 volume with 155 trades. The average volume for the last 3 months is 21,337 and the stock's 52-week low/high is $1.889/$4.23.

chart

Body and Mind, Inc. (BMMJ)

MicroSmallCap, New Cannabis Ventures, Wallet Investor, GuruFocus, Trading View, Simply Wall St, The Street, Barchart, InvestorsHub, Penny Stock Tweets, Dividend Investor, Wallmine, Market News Updates, PotStockNews, Investor Ideas, Stockhouse, Insider Financial, Morningstar, Midas Letter, and Canadian Insider reported earlier on Body and Mind, Inc. (BMMJ), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Body and Mind, Inc. invests in high quality medical and recreational cannabis cultivation, production and retail. Its wholly-owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licences. Additionally, the Company holds cultivation and production licenses. Body and Mind (BaM) products include dried flower, edibles, topicals, extracts, and GPEN Gio cartridges. Body and Mind is headquartered in Vancouver, British Columbia.

The Company has collected, for many years', elite cannabis plants from all over the world. Through carefully crossbreeding these plants, it has developed strains that give what it states are the perfect balance of body and mind benefits.

The Company's cannabis plants are grown with hands-on care in small batches. Furthermore, Body and Mind never uses synthetic pesticides. It offers a variety of strains, available in flower, vapes, pre-rolls and concentrates.

Body and Mind announced in February 2019 that the Clubhouse dispensary in Ohio received final approvals from the Ohio Board of Pharmacy and Elyria City Council to open the dispensary on February 22, 2019. Nevada Medical Group LLC (NMG Nevada), a wholly-owned subsidiary of the Company, earlier entered into a definitive agreement where NMG Nevada will acquire 100 percent ownership of NMG Ohio LLC.

NMG Nevada, which previously held a 30 percent interest in NMG Ohio, will purchase the remaining 70 percent interest for fair value consideration of USD $3,150,000. NMG Ohio owns a dispensary in Loraine County, Elyria and a production license.

Body and Mind announced this past March expansion into Arkansas with in-State partner, Comprehensive Care Group LLC (CCG). The companies will work together to develop a medical marijuana dispensary facility in West Memphis, Arkansas. Medical marijuana dispensaries in Arkansas are licensed for retail sales and cultivation of up to 50 plants within the same facility.

Recently, Body and Mind announced it signed a long term lease to relocate its production facility to a new campus located within one mile of the Pepper Lane cultivation facility. The new facility is about 7,500 square feet. It is anticipated to be operational within 90 days pending license transfer approvals from local and state authorities. Body and Mind's plan is to move the current production licence and it will not need to apply for a new license to produce edibles, oils and extracts.

Mr. Robert Hasman, President of Nevada Medical Group LLC and Board member of Body and Mind, said, "This is an exciting development for BaM as our production output has been limited by space constraints. The new facility will enable us to meet the increased demand for our products, allow us to better serve our distribution partners, and allow us to introduce new products. It is anticipated that the BaM product lines will be introduced into the other states in which we have a presence in the near term."

Body and Mind, Inc. (BMMJ), closed Thursday's trading session at $2.03967, up 1.98%, on 140,856 volume with 221 trades. The average volume for the last 3 months is 460,227 and the stock's 52-week low/high is $0.259/$2.70.

chart

Ensign Energy Services, Inc. (ESVIF)

Stock Target Advisor, All Stocks Today, Street Insider, Capital Cube, Marketbeat, Wallmine, Market Screener, Stockhouse, Wallet Investor, Dividend Investor, Dividend Channel, and Stockwatch reported earlier on Ensign Energy Services, Inc. (ESVIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Ensign Energy Services, Inc., together with its subsidiaries, provides oilfield services to the oil and natural gas industry in the United States, Canada, and worldwide. The Company is an international leader in drilling and servicing wells. As of December 31, 2018, it owned and operated a fleet of 335 land drilling rigs, 27 specialty rigs, 110 well servicing rigs, and 5 drilling rigs via Trinidad Drilling International. Ensign Energy Services is headquartered in Calgary, Alberta.

The Company's services include drilling, directional drilling, and well servicing. Ensign's crews work in the world's most extreme environments, from arctic to equatorial, desert to rainforest. Regarding drilling, Ensign Energy Services offers its clients an extensive fleet of technologically advanced, purpose-built rigs and a comprehensive range of drilling services.

Concerning directional drilling, the Company is an industry leader in the drilling of deep, complex, challenging wells. Its horizontal and directional drilling teams are among the world's most skilled and experienced. Moreover, they are fully equipped with state-of-the-art technology.

Pertaining to servicing, Ensign's service rigs are purpose-built for industry. The design of them are to move safely, quickly, as well as efficiently. The Company's fleet has hundreds of rigs deployed around the world. Furthermore, Ensign's highly trained, experienced crews are backed by a complete lineup of service rigs to handle the most challenging environments.

This week, Ensign Energy Services reported 2019 Q1 results. Revenue for the three months ended March 31, 2019 was $445.3 million. This represents an increase of 72 percent from Revenue for the three months ended March 31, 2018 of $258.5 million. Revenue, net of third party, for the three months ended March 31, 2019 was $412.4 million. This represents an increase of 82 percent from Revenue, net of third party, for the three months ended March 31, 2018 of $227.0 million.

Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) totaled $115.5 million ($0.74 per common share) in Q1 of 2019, higher by $63.2 million than Adjusted EBITDA of $52.3 million ($0.33 per common share) in Q1 of 2018. Net Loss Attributed to Shareholders for the three months ended March 31, 2019 was $22.3 million ($0.14 per common share), versus a Net Loss Attributed to Shareholders of $26.7 million ($0.17 per common share) for the three months ended March 31, 2018.

                   

Ensign Energy Services, Inc. (ESVIF), closed Thursday's trading session at $4.34, up 10.71%, on 500 volume with 4 trades. The average volume for the last 3 months is 581 and the stock's 52-week low/high is $3.13/$5.50.

chart

Norwegian Air Shuttle ASA (NWARF)

Penny Stock Tweets, All Stocks Today, Investor Place, News Quantified, Investors Hangout, Street Insider, Marketbeat, Stockhouse, Dividend Investor, Wallet Investor, GuruFocus, Equities, Market Screener, and Trading View reported earlier on Norwegian Air Shuttle ASA (NWARF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Norwegian Air Shuttle ASA, together with its subsidiaries, provides scheduled and charter airline services in Norway and around the world. In addition, the Company is also involved in aircraft financing, leasing, and ownership activities; commercial cargo activities; and provision of crew, airline operative support, administrative, and ground handling services, and holiday packages via a Web booking portal. Norwegian Air Shuttle lists on the OTC Markets. The Company has its corporate headquarters in Bærum, Norway.

As of December 31, 2018, Norwegian Air Shuttle operated a fleet of 195 owned and leased aircrafts in roughly 500 routes to 150 destinations across Europe into North Africa, the Middle East, North America, the Caribbean, South America, and South-East Asia.

The Company's fleet includes Boeing 737-800s, Boeing 737 MAX aircraft and Boeing 787 Dreamliners. Norwegian Air Shuttle has one of the youngest and greenest fleets in the world, with an average fleet age of 3.8 years.

The Company has 35 787 Dreamliner aircraft. The 787-8 has 291 seats (32 in the Premium cabin and 259 in the Economy cabin). The 787-9 has 344 seats (35 in the Premium cabin and 309 in the Economy cabin). The cruise speed is 913 kph. Norwegian's 787 Dreamliners are fitted with the Boeing Sky Interior for improved passenger comfort.

For five years in a row, from 2013 to 2018, Norwegian Air Shuttle gas been voted by passengers in the Skytrax Awards as Europe's Best Low-Cost Airline. For three years in a row, 2016, 2017 and 2018, the Company has been voted by passengers in the Skytrax Awards as The World's Best Low-Cost, Long Haul Airline.

Norwegian Air Shuttle has its Norwegian - On Air. This is the Company's own podcast. The podcast is mainly made for investors, but also Norwegian-colleagues and others who are interested in Norwegiann Air Shuttle ASA.

Norwegian Air Shuttle ASA (NWARF), closed Wednesday's trading session at $0.7175, down 4.33%, on 63,117 volume with 50 trades. The average volume for the last 3 months is 61,004 and the stock's 52-week low/high is $0.704/$2.69.

chart

CannaPharmaRX, Inc. (CPMD)

Hottest Stock Picks, Real Investment Advice, Stockaholics, Zacks, Infront Analytics, Capital Cube, Morningstar, Stockhouse, Barchart, The Street, Simply Wall St, GuruFocus, Insider Tracking, Daily Marijuana Observer, Stockopedia, Dividend Investors, The Seed Investor, PR Newswire, Marketwired, Seeking Alpha, InvestorsHub, Wallet Investor, Stockwatch, and 4-Traders reported beforehand on CannaPharmaRX, Inc. (CPMD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Based in Irvine, California, CannaPharmaRX, Inc. focuses on the acquisition and development of state-of-the-art cannabis grow facilities located in Canada. The Company's business strategy is to become a leader in high quality and low-cost production of cannabis in Canada via the development, acquisition and enhancement of existing facilities. CannaPharmaRx's dedication is to operating high quality facilities employing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis. CannaPharmaRX lists on the OTC Markets.

The Company's corporate mission is to produce high quality, carbon footprint efficient pharmaceutical grade medical cannabis in ultramodern, highly efficient facilities in Canada for the distribution to wholesale licensed retailers across the nation. CannaPharmaRX's vision is the immediate national expansion via acquisitions for the continuing development of cannabis production facilities.

Recently, the Company completed an initial acquisition of a 48,500 square foot cannabis grow facility now under development. CannaPharmaRX is presently in discussions with other companies concerning potential acquisitions or business combinations. It is currently targeting acquisitions of companies in the final stages of obtaining cannabis licensee applications or those which are nearing revenue generation.

The Company's Hanover facility in the Province of Ontario includes 10 acres of land and a 48.8 thousand square foot growing space to produce 9.6 thousand kg of cannabis each year. Construction is underway and the projection is to complete by September of this year. CannaPharmaRX is projected to be licensed to cultivate, granted by Health Canada October 2019, and licensed to sell, granted by Health Canada December 2019; its sales will begin immediately.

This past January, CannaPharmaRX announced it completed the acquisition of Alternative Medical Solutions, Inc., (AMS), a Province of Ontario corporation. With this agreement, Hanover CPMD Acquisition Corp. (HCAC), a wholly-owned subsidiary of CannaPharmaRX, acquired all of the issued and outstanding securities of AMS for total consideration of CAD$12,710,000 comprising cash, common stock, and a promissory note. AMS is a late stage marijuana licensed producer applicant in Canada presently operating in the Pre-License Inspection and Licensing phase, which is Stage 5 of 6, with a fully approved license.

Recently, CannaPharmaRx announced it completed the acquisition of a minority interest in GN Ventures, LTD., (GNC), a Province of Alberta corporation, engaged in the development of Canadian cannabis cultivation facilities. With this stock purchase agreement, the Company acquired roughly 18 percent of the issued and outstanding securities of GNC for total consideration of 7,998,963 shares of CPMD common stock. The Company also acquired warrants exercisable to purchase an additional 2,500,000 shares of GN at an exercise price of CAD$1.00 per share. GNC owns a 60,000 square foot cannabis cultivation and grow facility situated on 38 acres in Stevensville, Ontario.

CannaPharmaRX, Inc. (CPMD), closed Thursday's trading session at $1.90, up 2.70%, on 1,662 volume with 4 trades. The average volume for the last 3 months is 1,391 and the stock's 52-week low/high is $0.509/$4.00.

chart

Captor Capital Corp. (CPTRF)

Stock Talk Today, InvestorsHub, GlobeNewswire, Capital Market Review, Midas Letter, MarketWatch, TMXmoney, Stockhouse, Otc.watch, Seeking Alpha, GuruFocus, Stockwatch, The Street, Market Screener, YCharts, Dividend Investor, Baystreet, Morningstar, Zacks, Investors Hangout, Barchart, and Investorx reported earlier on Captor Capital Corp. (CPTRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Captor Capital Corp. is a vertically integrated investment company headquartered in Toronto, Ontario. It cultivates, manufactures and distributes recreational and medical marijuana based products to consumers via its leading brands and dispensary retail stores. At present, the Company has several revenue generating cannabis investments. This includes the CHAI Cannabis Co. dispensaries in Santa Cruz and Monterey. In addition, it owns Mellow Extracts, a highly regarded producer of cannabis extracts based in Costa Mesa, California.

Captor Capital owns and operates advanced growing facilities that produce consistent high-quality, contaminant-free marijuana and other high demand cannabis-based goods. The Company's strategy involves acquiring cash flowing established companies and organizations with growth potential that require capital to scale. Captor works to capitalize upon the combination of its intellectual property (IP) and wide-ranging network of industry relationships.

Captor Capital's dedication is to provide its customers with easy access to a broad array of products supported by first-rate service. Its stores are stylish, comfortable and designed for customers' enjoyment. The expectation is that the Company's revenue will surpass a run rate of $45 million, via ownership of leading brands and high value dispensary locations.

Last month, Captor Capital announced it qualified for trading on the OTCQX® Best Market (OTCQX). The Company upgraded to OTCQX from the Pink® market. The OTCQX Market is reserved for established, investor-focused U.S. and international companies that meet high financial standards, provide timely news and disclosure to investors.

Additionally, in March, Captor Capital announced that a wholly-owned subsidiary of the Company entered into a Letter of Intent (LOI) to acquire 100 per cent ownership of a Type 7 Volatile Solvent Extraction facility based in California from People's Holdings. People's is one of the largest manufacturers of THC concentrates in California. The facility is 4,000 square feet with trim supplier and distribution agreements in place producing AA-AAA quality THC distillate oil with a 90-95 percent cat3 pass rate.

This week, Captor Capital announced it entered into an LOI to form a Joint Venture Company (JVCo) with Green Buddha Group LLC, a company with significant cannabis assets in Michigan, including retail operations presently generating sales, and cultivation and manufacturing facilities now under development.

With this LOI, Green Buddha will transfer to JVCo Michigan licenses to operate 20 retail medical cannabis retailers, two licenses to operate a cannabis manufacturing, processing, and extraction facility, and eight licenses to operate a 325,000 sq. ft. cannabis cultivation facility (the Michigan Licenses). Captor Capital has agreed to provide JVCo a convertible loan to finance the exploitation of the Michigan Licenses and the build-out and operation of JVCo's retail processing and cultivation facilities.

The loan is convertible into 50.1 per cent of the issued and outstanding shares of JVCo.  Upon conversion of the loan, Green Buddha Group would own 49.9 per cent of JVCo.

Captor Capital Corp. (CPTRF), closed Thursday's trading session at $1.0056, up 3.19%, on 30,516 volume with 32 trades. The average volume for the last 3 months is 19,202 and the stock's 52-week low/high is $0.55/$2.14.

chart

Ionix Technology, Inc. (IINX)

Small Cap Exclusive, Market Exclusive, Wallmine, OTC Markets, Simply Wall St, Stockhouse, Financial Content, Wallet Investor, YCharts, Barchart, The Street, Morningstar, MarketWatch, Stockopedia, Last10k, Dividend Investor, Open Insider, and Current Charts reported previously on Ionix Technology, Inc. (IINX), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Ionix Technology, Inc. is a business aggregator in photoelectric display and smart energy fields. It is concentrating on becoming the business aggregator that primarily promotes photoelectric display, smart energy and lead industrial technology development since restructuring. Through incorporating high quality enterprises and innovating forward-looking technologies, Ionix provides more optimized green energy solutions. The Company previously went by the name Cambridge Projects, Inc. It changed its name to Ionix Technology, Inc. in February of 2016.

Ionix Technology has four operating subsidiaries. One is Changchun Fangguan Photoelectric Display Technology Co., Ltd, which specializes in developing, designing, producing, and selling TN and STN LCD, STN, CSTN, and TFT LCD modules and other related products. Another subsidiary is Shenzhen Baileqi Electronic Technology Co., Ltd, which specializes in LCD slicing, filling, researching and designing, manufacturing and selling of LCD Modules (LCM) and PCBs.

Subsidiary Lisite Science Technology (Shenzhen) Co., Ltd., engages in the production of intelligent electronic devices. Furthermore, subsidiary Dalian Shizhe New Energy Technology Co., Ltd., engages in photo-voltaic power generation, electric vehicles and charging piles with corresponding operation and maintenance and three-dimensional parking. At present, the Company has embarked on the layout of industrialization and marketization of front end materials and back end modules of flexible folding liquid crystal displays by taking Changchun Fangguan and Shenzhen Baileqi as production bases, to capture the market share of OLED high technology.

This past January, Ionix Technology announced that it entered into certain VIE Transaction Documents with certain shareholders of Changchun Fangguan Electronics Technology Co., Ltd. Changchun Fangguan is a top manufacturer in the liquid crystal displays field. Through entering into specific VIE Transaction Documents, Ionix acquired control of Changchun Fangguan.

Yubao Liu, Chief Executive Officer of Ionix Technology, said, "This acquisition of control of Changchun Fangguan is a great milestone for our company's development, and a crucial part of corporate restructuring strategy. As a pioneer in the field of LCDs in China, Changchun Fangguan is one of the few domestic LCD manufacturers that is capable of meeting the industry needs as well as providing LCD, LCM and TFT-LCM products in batches."

Last week, Ionix Technology announced that its subsidiary Changchun Fangguan Electronics Technology Co., Ltd. completed a capital increase of USD 5.92 Million to invest in its OLED flexible screen business. In December of 2018, Ionix Technology acquired 95.14 percent control of Changchun Fangguan. Thus, Ionix became an aggregator in the photoelectric display and smart energy fields in China, which has also laid a strong basis for its prospective future development and technology innovation.

Ionix Technology, Inc. (IINX), closed Thursday's trading session at $1.60, up 17.65%, on 10,700 volume with 22 trades. The average volume for the last 3 months is 2,300 and the stock's 52-week low/high is $1.02/$2.75.

chart

Bionik Laboratories Corp. (BNKL)

Stockhouse, Wallet Investor, Zacks, Business Wire, The Street, Seeking Alpha, MarketWatch, InvestorsHub, PR Newswire, and YCharts reported earlier on Bionik Laboratories Corp. (BNKL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A robotics company, Bionik Laboratories Corp. concentrates on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home. The Company has three products on the market and four products in different stages of development. These products are focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients. Bionik Laboratories has its head office in Toronto, Ontario and has its U.S. headquarters in Watertown, Massachusetts. The Company lists on the OTC Markets' OTCQB.

Bionik Laboratories' products include InMotion ARM ™; InMotion HAND™, and InMotion WRIST™. InMotionRobots™ are for all stages of recovery – from acute to chronic. The Company's family of robotic rehabilitation products are the result of pioneering medical engineering research and development (R&D) at the Newman Laboratory for Biomechanics and Human Rehabilitation at the Massachusetts Institute of Technology (MIT).

The design of Bionik Laboratories' modular systems approach to neurorehabilitation is to optimize the use of robotics in a way consistent with the most contemporary clinical research and neuroscience. This is while considering the latest understanding on motor learning interference and motor memory consolidation.

Regarding its technology, the Company's robotic products have excellent capacity for measurement and immediate interactive response. These products sense the patient's movement and respond to a patient's continually-changing ability. Moreover, robots guide the exercise treatment accordingly and provide quantifiable feedback on progress and performance. In addition, If the patient cannot move, the robot gently assists the patient to initiate movement towards the target.

This past January, Bionik Laboratories announced the commercial launch of its newest generation InMotion ARM/HAND™ robotic system for clinical rehabilitation of stroke survivors and those with mobility impairments because of neurological conditions. It showcased the new technology for the first time at the American Physical Therapy Association Combined Sections Meeting (APTA CSM) that took place January 23-26, 2019 at the Walter E. Washington Convention Center in Washington, D.C.

For the remainder of Fiscal Year (FY) 2019, Bionik Laboratories is working to continue to expand sales channels in North America and internationally. The Company is also working to further develop InMotion robotic products to serve clinical rehabilitation providers and to provide home based solutions for extended rehabilitation therapy and mobility enhancement.

Moreover, Bionik will work in FY 2019 to enhance the effectiveness of its commercial outsourced manufacturing to support the anticipated boost in product demand and introduction of new products. In addition, it will focus on increasing sales of service contracts and warranties.

Bionik Laboratories Corp. (BNKL), closed Thursday's trading session at $4.00, up 99.00%, on 585 volume with 5 trades. The average volume for the last 3 months is 237 and the stock's 52-week low/high is $1.00/$100.00.

chart

Bluestone Resources, Inc. (BBSRF)

Stock Orange, Wallmine, Barchart, OtcStockWatch, Penny Stock Hub, Current Charts, Dividend Investor, Investors Hangout, OTC Markets, MarketWatch, 4-Traders, and Geology for Investors reported earlier on Bluestone Resources, Inc. (BBSRF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Bluestone Resources, Inc. centers on advancing its 100 percent owned Cerro Blanco Gold and Mita Geothermal Projects in Guatemala. The Company controls the required surface rights for the Mita Geothermal Project and the Cerro Blanco Project. The Cerro Blanco Project is a classic hot springs-related, low sulphidation gold-silver deposit. A mineral exploration and development enterprise, Bluestone Resources is based in Vancouver, British Columbia and lists on the OTC Markets' OTCQB.

The Mita geothermal resource was discovered in the late 1990's during gold exploration in southeastern Guatemala. The permitted Mita Geothermal Project is contiguous to Bluestone Resources' Cerro Blanco Gold Project in Guatemala. It is in southeast Guatemala, about 160 kilometers by road from the capital, Guatemala City.

The Cerro Blanco Project economics and updated mineral resource estimate for Cerro Blanco indicates a strong project with an expected nine-year mine life producing 952,000 ounces of gold and 3,141,000 ounces of silver. Initial capital expenditures estimated in the Preliminary Economic Assessment (PEA) to finance construction and commissioning is estimated at US$170.8 million with all in sustaining cash (AISC) estimated to be US$490 per ounce of gold produced.

The Cerro Blanco Gold Project is not dependent on the Mita Geothermal Project. Nonetheless, Company Management's belief is that there are potential synergies between the two that enhance the economics of the Cerro Blanco Gold Project beyond what was outlined in the PEA.

Bluestone Resources announced in February 2019 the results of the Independent Feasibility Study prepared in accordance with National Instrument 43-101 (NI 43-101) for its 100 percent owned high-grade Cerro Blanco Gold project. The Feasibility Study demonstrates that the Project represents a strong, fast pay-back, high-grade underground mining operation.

Also in February, Bluestone Resources announced that the 43-101 feasibility study technical report for the Cerro Blanco Gold Project in Guatemala was filed and is available for review under Bluestone's profile on SEDAR at www.sedar.com and on the Company's website at www.bluestoneresources.ca.

Last month, Bluestone Resources announced additional high-grade intercepts from the infill resource drill program at its Cerro Blanco Gold Project. The principal emphasis of the program is to upgrade Inferred Resources identified during the prior drill program completed in 2018. Furthermore, the design of the program is to define new resources along known veins in the mine plan that extend outside of the present resource envelope. The Step-Out drill hole intercepted 201.4 g/t Au and 2,139 g/t Ag over 1 meter at Cerro Blanco - 20 meters outside of the current resource envelope.

Bluestone Resources, Inc. (BBSRF), closed Thursday's trading session at $0.7398, up 1.06%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 9,477 and the stock's 52-week low/high is $0.7106/$1.159.

chart

DXI Energy, Inc. (DXIEF)

Stockfuse, MarketWatch, InvestorsHub, Zacks, Oilandgas360, Tip Ranks, Wallet Investor, Stock Digest, Amigo Bulls, Dividend Investor, Stockhouse, Private Capital News Wire, Stockwatch, Equity Clock, The Street, Barchart, Marketwired, YCharts, Capital Cube, Street Insider, Marketbeat, ValueForum, and Seeking Alpha reported on DXI Energy, Inc. (DXIEF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

DXI Energy, Inc. is a tactical acquisitor and developer of strategic energy resources. The Company is an upstream oil and gas exploration and production company. DXI Energy operates in Colorado's Piceance Basin and in the Peace River Arch area in British Columbia  (B.C.). DXI Energy has offices in Calgary, Alberta, and Vancouver, British Columbia. The Company's shares trade on the OTC Markets' OTCQB.

In Colorado's Piceance Basin, DXI Energy has 24,407 net acres.  In the Peace River Arch area in B.C. it has 13,093 net acres. Concerning its project areas, in the Piceance Basin in northwest Colorado, DXI has its Kokopelli project with 12 producing wells with extensive in place infrastructure to supplement future development as product prices dictate. 

The Company's land holdings in the Piceance Basin highlight potential long-term regional resource value. This is as utilities develop sources of natural gas. For Kokopelli, DXI Energy retains a 25 percent Working Interest (WI) in 2,200 acres (550 net, 2 leases). 

In addition, DXI has its Roan Creek project (West Piceance Hi-Pressure Mancos/Niobrara Gas). This project is 1,960 net acres, 100 percent WI. There is potential development of 8-10 high pressure Mancos/Niobrara 8200' vertical/Hz wells.

The Woodrush Project in northeastern B.C. encompasses 14,444 net acres (20.701 (gross) with 12 wells (3 oil and gas, 9 natural gas). DXI is the operator and it owns 99 percent of the Project. The Company has a multi-phase plan to expand production and landholdings at the Woodrush Project. It has $13mm invested in production facilities and a related network of pipelines at the Woodrush Project.

Earlier this month, DXI Energy announced that it received all B.C. Oil & Gas Commission (BCOGC) permits to begin the drilling of a key Halfway formation exploration well at its Woodrush NE B.C. complex. Contracts for the building of road access and an environmentally modified drill pad meeting specs of all First Nation stakeholders were issued; construction is underway.

Chief Financial Officer, Mr. David Matheson, said, "With the permit to drill from the BCOGC (inclusive of all other stakeholders), we will now test the voracity of the Paradigm 3D seismic imaging and interpretation software with the drilling and completion of this important Woodrush Halfway pool test prior to winter 2019 break up."

DXI Energy, Inc. (DXIEF), closed Thursday's trading session at $0.03, up 19.52%, on 27,811 volume with 10 trades. The average volume for the last 3 months is 119,290 and the stock's 52-week low/high is $0.0104/$0.082.

chart

Alternate Health Corp. (AHGIF)

Wallet Investor, Weed Newswire, GuruFocus, CannabisFN, OTC Markets, Marijuana Index, Stockhouse, MicroCapFinder, OTC Insider, MarketWatch, InvestorsHub, The Street, Daily Marijuana Observer, Investing News, Trading View, Cannabis Life Network, and Market Screener reported earlier on Alternate Health Corp. (AHGIF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Alternate Health Corp. is a global cannabis company listed on the OTC Markets' OTCQB. It provides software solutions for the medical cannabis industry. The Company utilizes best in class technology, research, education, production, and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices. Alternate Health has its headquarters in Toronto, Ontario. The Company has additional offices in Venice and Humboldt County, California and San Antonio, Texas.

Alternate Health is a diversified healthcare investment and Holdings Company. It operates via a network of subsidiaries that share proprietary, highly secure cloud-based software solutions to increase efficiencies and protect patient data. Its companies are: Alternate Health Clinics; Alternate Health Labs; Alternate Medical Media; Alternate RX; CanaPass, Inc.; and VIP-Patient.

Alternate Health develops software applications and processing systems for the medical industry employing proprietary technology platforms (VIP-Patient & CanaPass systems) to assist doctors in their practice management and patients with their need for first-rate medical care. Alternate Health's services include practice management and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the developing medical cannabis industry.

The Company has transformed the CanaPass Patient Management system to a total Ethereum-based blockchain Electronic Medical Records (EMR)/Electronic Health Records (HER) system. Alternate Health has taken a leadership position in blockchain financial and healthcare solutions. CanaPass, Inc. provides turnkey compliance management software to doctors and Licensed Providers of medical cannabis and other controlled substances.

A key product is its Zi App Blockchain Payment Gateway. The design of it was originally to enable digital payments in cannabis. However, the system has earned considerable interest as a payment solution for even larger markets. This includes multi-level marketing, commercial leases, as well as equipment rentals.

Recently, Alternate Health announced that Mr. Kyle Kemper was appointed to the Company's Board of Directors. Mr. Kemper is the author of "The Unified Wallet: Unlocking the Digital Golden Age", which is a definitive work on the implications of blockchain technology in the modern world. He is a strong advocate for the expansion of blockchain and Bitcoin.

Mr. Howard Mann, Chief Executive Officer of Alternate Health, said, "We are thrilled to welcome Mr. Kemper to Alternate Health's Board of Directors. His deep technical knowledge, vision for what's possible and network of industry contacts are valuable assets to the Company as we take the lead in both blockchain technology and cannabis."

Alternate Health Corp. (AHGIF), closed Thursday's trading session at $0.484, up 21.00%, on 213,180 volume with 118 trades. The average volume for the last 3 months is 43,173 and the stock's 52-week low/high is $0.2175/$0.836.

chart

The QualityStocks Company Corner

IONIC Brands Corp. (CSE: IONC) (OTC: ZRRRF)

The QualityStocks Daily Newsletter would like to spotlight IONIC Brands Corp. (OTC: ZRRRF).

IONIC Brands Corp. (CSE: IONC) (OTC: ZRRRF) was featured today in a publication from NetworkNewsWire explaining why the company is "One to Watch."

IONIC Brands Corp. (CSE: IONC) (OTC: ZRRRF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in markets across the western United States. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.

With a focus on quality, responsibility and respectability, IONIC's product lines are pioneering the changing landscape of cannabis consumption. The company's refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.

IONIC's Certified Clean program verifies that every product leaving the company's facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green's technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package's QR code with a smartphone camera.

Elite Brand Portfolio/Acquisitions

  • IONIC, the company's flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC's immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
  • WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
  • ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
  • Vuber Technologies hardware produces the best vaporization experience on the market.
  • Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
  • Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.

IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.

Experienced Management Team

IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.

Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC's expansion and development into Washington state's leading vaporizer brand.

Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.

Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck's.

Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC's aggressive sales growth plans across multiple states.

In 2018, IONIC was voted one of the "Top 50 Companies to Work for in Cannabis" by MG Magazine, a publication serving cannabis industry professionals.

IONIC Brands Corp. (OTC: ZRRRF), closed the day's trading session at $0.3287, off by 21.07%, on 798,946 volume with 322 trades. The average volume for the last 3 months is 233,137 and the stock's 52-week low/high is $0.0359/$0.635.

Recent News

chart

Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGRMF).

Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF) was featured today in a publication from PotStockNews, noting that Organigram is one of the few cannabis stocks which has been consistently trading above the 50-Day Moving Average Price.

Organigram Holdings Inc. (TSX.V: OGI) (OTC: OGRMF) is the parent company of Organigram Inc., an original and leading Canadian licensed producer ("LP") of premium, quality cannabis and extract-based products. Founded in 2013 and headquartered in Moncton, New Brunswick, Canada, Organigram is focused on producing the highest-quality indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company's global footprint.?

Organigram delivers industry-leading yields and maximizes cannabis production at the lowest cultivation cost among other Canadian licensed producers. Organigram's high-tech facilities utilize an efficient, state-of-the-art mechanical room that includes both ethanol and CO2 extraction methods.

The company first began as a medical cannabis provider producing 5,000 kg/year (11,000 lbs) of 100 percent organic cannabis grown in pre-fabricated grow pods. Within two years, Organigram increased production to 36,000 kg/year (70,000 lbs) by utilizing an inventive, indoor 3-tier growing system. The company's pharmaceutical grade, state-of-the-art facility currently houses over 45,000 flowering plants growing at any one time.

Organigram's head office, production facility and research & development program are located on the company's 14-acre campus that houses several buildings and a 40-megawatt substation. Leading the way with a proprietary software system that acts as the nervous system of the entire organization, Organigram's team employs a data-driven decision-making process that ensures efficiency and top yields. Numerous design and automation improvements include an ergonomically friendly grow room design, automatic potting machines and automated packaging lines, and larger propagation rooms with advanced environmental systems.

Organigram's fully funded Phase 4 expansion is underway which, when complete by fall of 2019, will bring production capacity of high-quality premium cannabis to 113,000 kg/year (249,000 lbs). The Company has also invested in Hyasynth, a Montreal-based biotechnology company and leader in the field of cannabinoid science and biosynthesis. Hyasynth has developed a disruptive technology using patented enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation.

Organigram expects to double its workforce within the year to accommodate increasing growth as the facility expands to 480,000 square feet of production space at full buildout. In September 2017, Organigram signed the first ever recreational cannabis supply agreement in Canada with the Province of New Brunswick. Since then, Organigram has signed similar supply agreements with nine out of 10 provinces, has already exported product out of Canada, and is currently working with German medical cannabis provider, Alpha-cannabis, and Serbia-based Eviana Health Corp. (CSE: EHC), a hemp farm and processing facility.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado, with 16 retail locations, for development of commercial scale extraction and product processing, along with derivative product development (edibles, vaporizable products and beverage product mixes). Organigram's partnership with Canada's Smartest Kitchen, a leader in food product development, will expand and develop the Company's edibles R&D program and creation of premium chocolate products. Organigram has also signed a multi-year extraction contract with Valens GroWorks Corp. for Valens to produce extract concentrate for oils and derivative products.

Organigram is well-positioned in the cannabis space with several adult-use recreational product lines. These include:

  • Trailblazer offers a consistent value with a pre-roll, milled format
  • Trailer Park Buds provides niche equity for mainstream users that seek pre-rolls
  • Ankr Organics offers premium, organic pre-roll and oils
  • Edison Cannabis Co. delivers robust, high THC in a whole flower, pre-roll and oil produced from premium sorted flowers
  • Edison Cannabis Co. Reserve offers an ultra-premium, large whole flower that is craft cured and hand trimmed

Experienced Executive Team

  • CEO Gregory Engel has more than 30 years of experience in the pharmaceutical industry with over three years of experience as a CEO for a cannabis company.
  • Jeff Purcell, senior vice president of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods.
  • Tim Emberg, senior vice president of sales and commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and consumer packed good industry.
  • Guillermo Delmonte, president of international operations, brings experience in leading a global cannabis company and worked for 2.5 years as CEO of ICC Labs Inc. in Uruguay.
  • Larry Rogers, vice president of international operations, has held roles for Organigram since 2014 including being a member of the board of directors, chief operating officer and vice president/business development.
  • Paolo DeLuca, chief financial officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities.
  • Ray Gracewood, chief commercial officer, has 15 years of experience in the marketing space and is a previous senior director of sales and marketing for Moosehead Breweries Ltd.
  • Michael Tripp, chief legal officer, worked for private practices at respected business law firms in Moncton and Toronto where he acted on over $3 billion in transactions.

Organigram Holdings Inc. (OTCQX: OGRMF), closed the day's trading session at $7.758, up 5.77%, on 1,026,626 volume with 1,858 trades. The average volume for the last 3 months is 890,736 and the stock's 52-week low/high is $2.97/$7.76.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) ("GGB" or the "Company") is pleased to announce that it has completed the repurchase (the "Repurchase Transaction") and cancellation of 27,300,000 of its common shares held by GA Opportunities Corp. ("GAOC") (previously announced on April 15, 2019), representing approximately 13% of its outstanding shares. Aggregate consideration for the Repurchase Transaction was C$89 million, or approximately C$3.26 per common share, at a significant discount to the current market price of GGB's common shares.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.44, up 2.08%, on 170,982 volume with 304 trades. The average volume for the last 3 months is 245,945 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Traditionally, consumers have relied on smoking to achieve higher absorption rates and fast onset of bioactive compounds such as nicotine and cannabinoids. Ingesting drugs and molecules through edibles is simply safer than inhaling them. However, the absorption of edibles has proven slow, and the taste can be unpleasant without the aid of sweeteners. Now, thanks to a revolutionary oral technology, it is possible to deliver bioactive substances via oral ingestion without the need for the unhealthy practices of inhalational or added sweeteners. Biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its drug-delivery platform, DehydraTECH, promoting healthier administration methods.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.00, up 3.09%, on 40,331 volume with 61 trades. The average volume for the last 3 months is 117,529 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech (OTCQB: ETST) aims to exploit the surging demand for cannabinoid products by offering first-class cannabinoids. An article discussing the company reads, "The company's cannabinoids are of the highest purity and quality on the market. To view the full article, visit: http://nnw.fm/eZr8c.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.55, up 1.85%, on 59,159 volume with 34 trades. The average volume for the last 3 months is 35,060 and the stock's 52-week low/high is $0.375/$2.45.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV:PQE; OTC:PQEFF; FSE: PQCF), at the request of the Market Surveillance group of the Investment Industry Regulatory Organization of Canada (IIROC), announces that the Company is not aware of any material undisclosed information that may be contributing to the level of trading activity of its shares on the TSX Venture Exchange.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PHVAF), closed the day's trading session at $0.42, up 0.24%, on 757,256 volume with 239 trades. The average volume for the last 3 months is 184,167 and the stock's 52-week low/high is $0.242/$1.43.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands LP (OTC: VPRB), an innovative technology holding company, recently reported its 2018 full-year financial results, which included impressive year-over-year ("YOY") revenue growth (http://nnw.fm/7wadP). To view the full article, visit: http://nnw.fm/tMkS9.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed the day's trading session at $0.0658, up 29.02%, on 54,480 volume with 7 trades. The average volume for the last 3 months is 77,177 and the stock's 52-week low/high is $0.026/$0.1397.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade Inc. (OTC:SGMD) announces the availability of a CannabisNewsAudio Broadcast titled, "Hemp Companies Move to Tackle CBD Shortfall." To hear the CannabisNewsAudio version, visit: http://cnw.fm/vs5Bu. To read the full editorial, visit: http://cnw.fm/46Hwn. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. As it becomes increasingly clear that the bill to legalize recreational marijuana is unlikely to get enough support in the New Jersey senate, lawmakers are beginning to consider the possibility of letting voters make the decision through a referendum in 2020.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.0339, up 1.19%, on 830,102 volume with 62 trades. The average volume for the last 3 months is 1,199,214 and the stock's 52-week low/high is $0.02995/$0.1975.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a publication from Financialnewsmedia.com, examining how reports show and predict that the U.S. will be at the epicenter of the global cannabis/marijuana markets.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.89, even for the day, on 562,649 volume with 62 trades. The average volume for the last 3 months is 1,196,549 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) and Blissco Cannabis Corp. ("Blissco") (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B:GR) are pleased to announce that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") under which Supreme Cannabis will acquire, by way of a court-approved plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement"), all of the issued and outstanding common shares of Blissco (the "Blissco Shares") not already owned by Supreme Cannabis. Also today, the company was featured in the Venture Breakfast Bits, by 24/7 Market News. Full press release. Additionally, the company was featured in the 420 with CNW by CannabisNewsWire.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.39, even for the day, on 332,225 volume with 434 trades. The average volume for the last 3 months is 598,218 and the stock's 52-week low/high is $0.85/$2.04.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO) ("PBI"), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, on Wednesday announced that it will host a teleconference to discuss its first quarter 2019 financial results and provide a business update. To view the full press release, visit: http://nnw.fm/4KShF.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.15, off by 5.41%, on 5,811 volume with 25 trades. The average volume for the last 3 months is 11,180 and the stock's 52-week low/high is $1.52/$4.10.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Geyser Brands Inc. (TSXV:GYSR) ("Geyser Brands" or the "Company") is pleased to announce its subsidiary, 0957102 B.C. DBA Apothecary Botanicals (the "LP"), has secured a Health Canada license amendment approval to make amendments to its current 7,000 sq. ft. facility located in Port Coquitlam, BC.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed the day's trading session at $0.75, off by 6.25%, on 3,000 volume with 2 trades. The average volume for the last 3 months is 8,575 and the stock's 52-week low/high is $0.61/$0.85.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company") is pleased to provide an update on its premium cannabis brand for the recreational market, CALIBER.  CALIBER is designed for the cannabis connoisseur and delivered via Sproutly's craft cannabis flower production.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.614, off by 0.16%, on 507,620 volume with 278 trades. The average volume for the last 3 months is 798,185 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTCQB: SING) Completes Asset Acquisition of Direct Solar, SinglePoint Largest Deal to Date Expects to Dramatically Increase Revenues. Direct Solar operates on a Lending Tree/Rocket Mortgage model in which the company provides the homeowners which options for installers that service their area and the loan programs they have access to. Video Introducing Direct Solar - https://www.youtube.com/watch?v=jl0u8eZpUrI&t=1s.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis' SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint's bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout's subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original "Shark Tank" member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet's secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary's product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation's largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint's chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0145, off by 2.03%, on 4,273,605 volume with 168 trades. The average volume for the last 3 months is 4,136,506 and the stock's 52-week low/high is $0.0106/$0.068.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.